We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Pacira BioSciences
PCRX
$1.02B
| $488K | 0.01% |
+10,680
| New | +$423K |
|
1227
Kilroy Realty
KRC
$4.58B
| $486K | 0.01% |
6,512
-15,101
| -70% | -$1.11M |
|
1228
Pool Corp
POOL
$6.7B
| $486K | 0.01% |
3,751
+1,262
| +51% | +$153K |
|
|
SVC
1229
Service Properties Trust
SVC
$1.1B
| $486K | 0.01% |
3,257
-6,527
| -67% | -$959K |
|
1230
Aclaris Therapeutics
ACRS
$730M
| $484K | 0.01% |
+19,616
| New | +$478K |
|
1231
Sonida Senior Living
SNDA
$1.97B
| $483K | 0.01% |
+2,385
| New | +$511K |
|
1232
Collegium Pharmaceutical
COLL
$1.14B
| $482K | 0.01% |
+26,095
| New | +$374K |
|
1233
CytomX Therapeutics
CTMX
$705M
| $482K | 0.01% |
22,837
+9,637
| +73% | +$200K |
|
|
RDUS
1234
DELISTED
Radius Health, Inc.
RDUS
| $482K | 0.01% |
+15,159
| New | +$476K |
|
1235
ONE Gas
OGS
$5.05B
| $480K | 0.01% |
+6,546
| New | +$496K |
|
|
ZGNX
1236
DELISTED
Zogenix, Inc.
ZGNX
| $480K | 0.01% |
+11,997
| New | +$461K |
|
1237
First Interstate BancSystem
FIBK
$3.7B
| $477K | 0.01% |
+11,906
| New | +$463K |
|
1238
Compass Minerals
CMP
$1.24B
| $476K | 0.01% |
+6,586
| New | +$443K |
|
|
MSGN
1239
DELISTED
MSG Networks Inc.
MSGN
| $476K | 0.01% |
+23,507
| New | +$453K |
|
|
CIM
1240
Chimera Investment
CIM
$1.05B
| $474K | 0.01% |
8,547
-13,154
| -61% | -$737K |
|
1241
Columbus McKinnon
CMCO
$465M
| $474K | 0.01% |
+11,848
| New | +$454K |
|
|
FNGN
1242
DELISTED
Financial Engines, Inc.
FNGN
| $474K | 0.01% |
+15,635
| New | +$491K |
|
1243
Autoliv
ALV
$8.6B
| $473K | 0.01% |
+5,169
| New | +$468K |
|
1244
Repligen
RGEN
$7.44B
| $473K | 0.01% |
13,044
-5,222
| -29% | -$189K |
|
1245
SPS Commerce
SPSC
$2.25B
| $473K | 0.01% |
19,480
+9,442
| +94% | +$242K |
|
1246
Constellium
CSTM
$3.96B
| $471K | 0.01% |
42,212
+26,212
| +164% | +$279K |
|
1247
Hubbell
HUBB
$25.7B
| $471K | 0.01% |
+3,480
| New | +$434K |
|
|
NXGN
1248
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $471K | 0.01% |
34,673
+8,047
| +30% | +$116K |
|
|
CDK
1249
DELISTED
CDK Global, Inc.
CDK
| $471K | 0.01% |
6,607
-5,356
| -45% | -$360K |
|
|
CEO
1250
DELISTED
CNOOC Limited
CEO
| $470K | 0.01% |
3,274
-779
| -19% | -$106K |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.